Results 121 to 130 of about 71,352 (148)
Circulating Claudin-5 and Systemic Inflammatory Indices in Wet and Dry Age-Related Macular Degeneration. [PDF]
Medicina (Kaunas)Çatak O, Keleş JK, Çatak Z.
europepmc +1 more source
Relative Risk of Neovascular Age-Related Macular Degeneration Following Cataract Surgery. [PDF]
JAMA OphthalmolBellanda V +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Age-related macular degeneration
Lancet, The, 2023Age-related macular degeneration is an increasingly important public health issue due to ageing populations and increased longevity. Age-related macular degeneration affects individuals older than 55 years and threatens high-acuity central vision required for important tasks such as reading, driving, and recognising faces.
Robyn Guymer
exaly +3 more sources
Age-related macular degeneration
Lancet, The, 2012Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in the developed world. Despite recent advances in treatment, AMD causes considerable morbidity. For the non-ophthalmologist, a brief background on retinal structure is provided, followed by a description of the characteristic changes seen in AMD.
Frank Holz
exaly +6 more sources
Age-Related Macular Degeneration
Primary Care - Clinics in Office Practice, 2015Age-related macular degeneration (AMD) is the leading cause of vision loss in the elderly. AMD is diagnosed based on characteristic retinal findings in individuals older than 50. Early detection and treatment are critical in increasing the likelihood of retaining good and functional vision.
Sonia Mehta
exaly +3 more sources
Age-related macular degeneration
British Journal of Hospital Medicine, 2005Age-related macular degeneration is the leading cause of irreversible loss of vision in the west, accounting for up to 50% of all blind registrations. With an ageing population age-related macular degeneration will have a discernible impact on society and the NHS.
Ahmed N, El-Amir +2 more
openaire +2 more sources
Age-related macular degeneration
NursingAbstract: Age-related macular degeneration (AMD) is the leading cause of visual impairment in patients age 50 and older, with an estimated 200 million people affected worldwide and a projected 288 million by 2040. This article provides an overview of the epidemiology, risk factors, pathophysiology, clinical manifestations, diagnosis ...
Monika, Fleckenstein +2 more
openaire +4 more sources
Age-related macular degeneration
Aging Clinical and Experimental Research, 1993Age-related macular degeneration (AMD), a bilateral, progressive macular disease, represents the major cause of blindness among elderly people living in Western countries. Clinical features of AMD vary from the initial asymptomatic aspects, drusen and retinal pigment epithelium alterations, to severe atrophic or exudative changes in the advanced stages,
T, Segato, E, Midena, M C, Blarzino
openaire +2 more sources
Age-related macular degeneration
The Lancet, 2018Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pigmentary changes) to late-stage (neovascular and atrophic). Age-related macular degeneration is a multifactorial disorder, with dysregulation in the complement, lipid, angiogenic,
Paul, Mitchell +3 more
openaire +2 more sources